| scholarly article | Q13442814 |
| P2093 | author name string | Wen-Cheng Lo | |
| Yung-Hsiao Chiang | |||
| Jiann-Her Lin | |||
| Yi-Shan Yang | |||
| Yi-Syue Tsou | |||
| P2860 | cites work | The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures | Q48522268 |
| Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP). | Q49722896 | ||
| Teriparatide Treatment in Elderly Patients With Sacral Insufficiency Fracture. | Q51049200 | ||
| Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture. | Q51214369 | ||
| [Clinical characteristics and risk factors of newly developed vertebral fractures after vertebral augmentation]. | Q53539417 | ||
| Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice | Q73003808 | ||
| Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis | Q79220334 | ||
| Repeated percutaneous vertebroplasty for refracture of cemented vertebrae | Q83061240 | ||
| Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures | Q84211314 | ||
| [Intermittent low-dose administration of recombinant human parathyroid hormone (1-34) promotes the expression of Runx2 during early stage of fracture healing] | Q84212901 | ||
| Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model | Q84896989 | ||
| Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women | Q84940845 | ||
| The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture | Q86933226 | ||
| Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders: A Multicenter, Prospective Randomized Stud | Q89378287 | ||
| [Clinical research of percutaneous vertebroplasty or percutaneous kyphoplasty for treating osteoporotic vertebral compression fractures induced by glucocorticosteroid] | Q95354524 | ||
| Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Q29619487 | ||
| A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research | Q30368733 | ||
| Histologic evaluation of human vertebral bodies after vertebral augmentation with polymethyl methacrylate | Q30964073 | ||
| No effect of teriparatide on migration in total knee replacement | Q33697036 | ||
| Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone | Q33857424 | ||
| Teriparatide improves early callus formation in distal radial fractures | Q33954158 | ||
| The impact of preoperative magnetic resonance images on outcome of cemented vertebrae | Q34338100 | ||
| Trend in hip fracture incidence and mortality in Korea: a prospective cohort study from 2002 to 2011 | Q35198607 | ||
| Predictive risk factors for refracture after percutaneous vertebroplasty | Q35843778 | ||
| Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. | Q35904457 | ||
| Refractures in cemented vertebrae after percutaneous vertebroplasty: a retrospective analysis | Q36542614 | ||
| Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial | Q36746818 | ||
| Effect of Teriparatide on Bone Formation in the Human Femoral Neck | Q36935517 | ||
| Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures | Q36993481 | ||
| PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures. A randomized, controlled study of 40 patients | Q37084451 | ||
| Fracture healing under healthy and inflammatory conditions | Q37980336 | ||
| Postvertebroplasty instability. | Q39253705 | ||
| Refractures in cemented vertebrae after percutaneous vertebroplasty and pain relief after a second procedure: a retrospective analysis | Q39303925 | ||
| Instability of treated vertebrae after balloon kyphoplasty causing paraparesis in osteoporotic vertebral compression fracture: a report of two cases | Q40285411 | ||
| Subsequent Vertebral Fractures Post Cement Augmentation of the Thoracolumbar Spine: Does it Correlate With Level-specific Bone Mineral Density Scores? | Q40699877 | ||
| Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks | Q43782888 | ||
| The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis | Q44590937 | ||
| Clinical evaluation of repeat percutaneous vertebroplasty for symptomatic cemented vertebrae | Q44775589 | ||
| Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening | Q44967763 | ||
| Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). | Q46289309 | ||
| Better Height Restoration, Greater Kyphosis Correction, and Fewer Refractures of Cemented Vertebrae by Using an Intravertebral Reduction Device: a 1-Year Follow-up Study | Q47318128 | ||
| Development of a Chinese version of the Oswestry Disability Index version 2.1. | Q47653123 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 6005 | |
| P577 | publication date | 2020-04-07 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Teriparatide Associated with Fewer Refractures and Higher Body Heights of Cemented Vertebrae after Vertebroplasty: A Matched Cohort Study | |
| P478 | volume | 10 |
Search more.